Therna Biosciences Launches with Proprietary Generative AI Models for Designing Programmable RNA Medicines

Therna Biosciences today announced its launch with a vision to transform the development of RNA medicines through a biology-guided, AI-powered platform. By decoding the language of RNA, Therna is pioneering programmable RNA therapeutics engineered for enhanced translation, durability, immune evasion, and precise tissue targeting – unlocking new levels of safety, efficacy, and therapeutic potential…